Idexx laboratories inc /de (IDXX)
CashFlow / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Dec'10Sep'10Jun'10Mar'10
Cash Flows from Operating Activities:
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest

436,939

427,792

422,925

407,301

390,280

377,047

329,660

306,960

283,687

263,269

277,350

263,288

245,087

222,054

214,073

201,850

191,582

192,135

173,696

181,630

181,936

181,951

199,237

192,766

189,520

187,794

187,917

185,098

182,420

178,287

172,925

168,548

165,882

161,754

160,136

156,355

144,898

141,320

0

0

0

Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization

89,860

88,011

86,026

84,458

83,729

83,178

84,094

83,943

83,637

83,140

81,861

80,901

79,979

78,218

75,706

74,222

71,348

68,956

66,505

63,743

61,648

58,888

57,076

55,328

54,477

54,596

55,048

54,074

53,216

52,408

51,304

50,550

49,443

48,202

47,227

46,667

46,174

45,956

0

0

0

Provision for credit losses

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Gain on disposal of property and equipment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

0

0

-

-328

-434

-388

-615

-580

-483

-817

-1,599

0

0

0

Impairment charge

-

-

-

-

-

-

-

-

-

-

-

-

-

2,228

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Increase (decrease) in deferred compensation liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

0

0

-

325

-154

-83

-171

-165

432

277

290

0

0

0

Provision for uncollectible accounts

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2,035

2,053

1,609

1,408

1,601

1,497

1,693

1,340

1,108

1,324

996

1,295

1,484

1,066

1,662

1,791

1,575

0

0

0

Benefit of deferred income taxes

5,721

6,162

-9,238

-4,003

1,498

1,209

5,370

-1,971

-6,854

-7,918

14,200

22,056

20,302

20,881

16,035

8,714

7,098

5,143

2,910

4,000

2,230

830

-3,672

-1,896

69

2,073

-1,093

-1,893

-1,263

-1,970

3,537

2,271

3,957

5,996

-1,689

1,596

824

-908

0

0

0

Share-based compensation expense

40,228

39,278

28,832

26,037

25,531

25,157

24,703

24,127

23,822

23,517

22,632

21,706

20,624

19,891

20,145

20,169

20,154

19,884

19,396

18,921

18,643

18,099

17,737

17,251

16,698

16,539

16,533

16,388

16,092

15,952

15,683

15,667

15,340

15,496

14,972

14,161

13,883

13,262

0

0

0

Other

978

1,254

7

29

67

895

1,480

1,589

1,238

1,007

1,011

477

1,260

986

1,720

651

-511

-472

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Tax benefit from share-based compensation arrangements

-

-

-

-

-

-

-

-

-

-

-

-

-

14,702

11,496

7,360

5,665

11,315

16,541

16,864

17,044

16,078

16,301

16,288

15,595

14,158

11,932

14,560

15,468

14,676

12,180

11,099

13,507

16,007

18,842

19,608

21,826

18,126

0

0

0

Changes in assets and liabilities:
Accounts receivable

27,113

22,472

9,811

23,228

30,022

18,401

39,235

25,390

27,289

24,918

24,631

31,307

20,479

22,554

15,765

16,663

20,208

50,142

46,186

50,966

33,357

3,626

11,615

1,571

13,931

15,946

9,563

12,482

2,417

-3,487

8,373

8,788

28,194

24,809

16,179

14,583

3,954

6,914

0

0

0

Inventories

37,219

37,306

34,790

31,709

32,074

25,623

23,511

17,037

21,763

19,062

12,815

11,416

-515

-7,648

10,234

18,732

23,063

34,969

52,910

48,758

50,652

38,310

3,769

1,983

-11,570

1,347

9,346

9,251

19,238

17,208

15,925

14,783

17,163

7,579

6,741

12,184

6,393

19,469

0

0

0

Other assets and liabilities

50,068

34,788

36,287

29,772

37,030

39,731

62

-13,063

-33,647

-47,418

10,623

4,941

2,288

-12,491

-19,367

-14,328

-10,519

-23,525

-31,232

-19,472

739

-11,319

-4,095

-4,830

-7,198

-12,187

-8,111

-11,176

-13,399

-3,933

3,856

11,468

11,050

1,339

4,316

4,281

8,103

13,208

0

0

0

Accounts payable

-497

1,957

2,351

-4,199

2,472

-166

3,595

-28

3,139

1,391

1,073

3,440

231

2,117

-2,123

623

63

-2,468

-3,014

3,374

514

6,703

-1,481

-10,528

-8,109

-4,399

5,953

10,327

-1,321

-2,898

-183

-746

16,457

13,015

5,680

6,176

-1,051

3,482

0

0

0

Deferred revenue

-11,672

-12,360

-12,231

-11,316

-9,490

-7,719

-5,042

-1,599

1,755

3,551

6,153

6,482

7,504

7,672

6,167

3,475

-835

-319

-59

5,350

12,121

14,195

13,958

12,217

8,800

6,442

5,787

5,516

6,058

6,888

9,474

10,708

9,395

7,341

2,818

181

1,491

2,370

0

0

0

Accrued liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

3,603

3,169

-1,331

187

-3,500

9,267

18,719

16,915

30,821

18,001

19,018

30,604

0

0

0

Net cash provided by operating activities

452,651

459,158

439,393

417,836

399,564

400,084

385,562

385,538

376,900

373,276

352,905

342,536

343,227

338,943

317,522

294,153

263,436

221,802

169,771

186,088

187,684

235,846

273,958

258,792

258,459

245,996

249,501

246,092

228,279

222,408

207,883

208,403

207,879

217,913

212,368

192,058

184,846

178,833

0

0

0

Cash Flows from Investing Activities:
Purchases of property and equipment

165,765

154,969

142,167

136,361

130,231

115,751

102,656

87,195

74,463

74,384

69,201

65,485

66,528

64,787

65,360

73,916

81,810

82,921

85,536

81,986

72,242

60,523

58,657

56,841

68,778

77,612

75,847

79,498

68,304

57,618

52,980

47,805

49,548

49,677

50,189

47,644

40,010

38,908

0

0

0

Purchases of marketable securities

-

-

-

-

-

87

64,453

158,729

243,759

334,164

318,863

279,607

246,307

227,894

219,400

205,397

203,589

271,958

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from the sale and maturities of marketable securities

-

-

-

-

-

284,125

346,068

414,981

483,408

286,759

276,398

251,647

221,149

203,859

184,341

154,851

123,733

56,775

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from disposition of pharmaceutical product lines

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3,500

3,500

3,500

3,500

3,000

3,000

3,000

3,000

3,000

0

0

0

-

-

-

0

Proceeds from sale of property and equipment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

45

47

52

145

225

249

266

167

112

0

0

0

Acquisitions of intangible assets

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

175

175

540

540

1,024

1,024

659

659

900

0

0

0

-

-

-

-

394

0

0

0

Acquisitions of businesses

-

-

-

-

-

-

-

-

-

14,579

0

0

0

-

-

-

-

10,302

25,799

24,337

24,337

25,115

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash used by investing activities

-216,992

-205,528

-149,461

-166,350

-159,916

138,602

153,959

166,687

150,636

-138,688

-128,479

-109,938

-95,999

-90,786

-102,521

-134,381

-171,585

-308,406

-318,011

-286,654

-228,399

-80,413

-61,770

-64,065

-81,402

-86,059

-86,130

-79,315

-68,078

-58,131

-95,990

-93,410

-95,060

-94,209

-53,690

-48,628

-41,093

-43,190

0

0

0

Cash Flows from Financing Activities:
Borrowing (repayments) on revolving credit facilities, net

139,859

-110,275

-185,072

-185,559

-60,564

-256,040

-271,750

-267,000

-263,500

44,000

198,250

146,000

49,000

38,000

-54,500

60,000

72,500

24,000

167,500

114,000

234,500

272,000

-22,200

16,500

55,000

65,000

165,200

123,500

6,000

-31,000

78,000

111,417

127,390

113,903

27,911

-1,470

-30,867

10,143

0

0

0

Issuance of senior notes

0

100,000

100,000

100,000

100,000

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Debt issuance costs

124

154

154

142

30

0

0

0

0

-

-

-

-

56

1,238

1,310

1,347

1,380

248

2,689

1,635

1,406

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Payment of acquisition-related contingent consideration

1,802

2,375

2,255

1,961

1,839

1,266

0

0

0

-

-

-

-

4,728

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Payment of notes payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,394

1,643

2,021

1,122

1,107

1,093

945

931

917

902

890

877

863

851

838

823

813

0

0

0

Issuance of long term debt

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Repurchases of common stock, net

430,171

301,658

266,576

254,429

340,134

369,319

317,584

301,651

302,142

282,565

441,217

398,348

314,516

304,086

184,486

258,420

321,814

401,981

458,247

641,629

681,526

618,158

553,819

358,052

374,262

367,761

324,026

283,597

168,416

132,268

180,641

212,092

243,195

255,505

191,949

157,785

125,302

143,090

0

0

0

Proceeds from exercises of stock options and employee stock purchase plans

34,765

36,106

32,345

35,949

35,201

38,201

41,903

37,357

40,647

38,622

40,843

43,960

45,110

38,344

31,991

24,301

15,832

22,397

30,302

30,385

30,803

29,442

34,862

36,522

36,241

38,235

28,744

30,339

31,352

24,166

19,877

19,681

22,404

28,801

32,890

31,786

34,551

28,865

0

0

0

Shares withheld for statutory tax withholding on restricted stock

9,254

8,053

8,114

8,227

8,223

9,375

9,354

9,334

9,325

8,073

8,469

8,099

7,911

4,372

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Tax benefit from share-based compensation arrangements

-

-

-

-

-

-

-

-

-

-

-

-

-

14,702

11,496

7,360

5,665

11,315

16,541

16,864

17,044

16,078

16,301

16,288

15,595

14,158

11,932

14,560

15,468

14,676

12,180

11,099

13,507

16,007

18,842

19,608

21,826

18,126

0

0

0

Net cash provided (used) by financing activities

-266,727

-286,409

-329,826

-314,369

-275,589

-597,799

-558,051

-541,628

-534,320

-208,016

-207,210

-208,586

-218,321

-222,196

-209,540

-179,956

-140,353

-100,990

5,945

-30,660

-51,677

-103,438

-178,832

-142,895

-119,663

-102,451

-119,243

-116,143

-116,527

-125,343

-71,486

-70,785

-80,771

-97,657

-113,157

-108,699

-100,615

-86,769

0

0

0

Net effect of changes in exchange rates on cash

-4,153

-689

-2,987

-831

-6,672

-4,768

-3,612

-2,013

5,605

6,202

1,731

824

-1,452

-54

3,461

-1,829

-705

-5,948

-9,290

-10,670

-11,651

-8,517

-5,432

2,203

445

-2,414

-758

-1,434

-801

1,157

-465

-1,793

-16

933

2,466

6,692

3,967

1,313

0

0

0

Net decrease in cash and cash equivalents

-35,221

-33,468

-42,881

-63,714

-42,613

-63,881

-22,142

8,584

-1,179

32,774

18,947

24,836

27,455

25,907

8,922

-22,013

-49,207

-193,542

-151,585

-141,896

-104,043

43,478

27,924

54,035

57,839

55,072

43,370

49,200

42,873

40,091

39,942

42,415

32,032

26,980

47,987

41,423

47,105

50,187

0

0

0

Supplemental Cash Flow Information:
Cash paid for income taxes

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Unpaid property and equipment, reflected in accounts payable and accrued liabilities

0

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Supplemental Disclosure of Non-Cash Information:
Market value of common shares received from employees in connection with share-based compensation - see Note 17

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-